Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Inhibitory potentials and kinetics of the inhibition of carbohydrate-hydrolysing enzymes by the pod and seed extracts of Lessertia montana (Fabaceae) E. Phillips & R.A. Dyer

Anofi Omotayo Tom Ashafa, Fatai Oladunni Balogun, Ademuyiwa Joshua Adegbegi.




Abstract
Cited by 9 Articles

The study evaluated the effect of extracts of the seeds and pod parts of Lessertia montana on diabetes and free radicals. Free radical scavenging activities of the extracts was tested against 1,1-diphenyl-2-picrylhydrazyl (DPPH), nitric oxide, 2,2-Azinobis (3-ethylbenzothiazoline-6) sulphonic acid (ABTS), hydroxyl radical and reducing power, metal chelating assays while the antidiabetic activity assessed via the inhibition and kinetics of alpha-amylase and alpha-glucosidase. The pod decoction extract revealed the best radical scavenging activities in DPPH, ABTS and metal chelating (with IC50 values 1371, 730, 798 µg/mL respectively) compared with other extracts and control having IC50 (3094, 4125 and 523 µg/mL respective) values. While the Aq.ethanolic extract for both parts exhibited highest reducing capabilities of 2.969 (pod) and 3.457 (seeds) at 1 mg/mL, the aqueous extract of the seed showed the best inhibitory activities in two of the six tested assays, namely, hydroxyl radical (717 µg/mL) and metal chelating (59 µg/mL). The kinetics of inhibition of α-amylase and α-glucosidase by Aq.ethanolic extract of the pod was competitive and non-competitive respectively while the two enzymes were uncompetitively inhibited by ethanolic extract of the seed. The investigation corroborated the antioxidative and antidiabetic potentials of the leaf as previously established from our group.

Key words: Antihyperglycaemic, free radicals, modes of inhibition, L. montana






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.